Caplin Point Labs Reports Strong Financial Performance in Q1, Indicating Positive Growth Trend
Caplin Point Laboratories, a midcap pharmaceutical company, recently announced its financial results for the quarter ending March 2024. The company has received a 'Hold' call from MarketsMOJO, indicating a neutral stance on its stock.Despite the challenging market conditions, Caplin Point Lab has shown a positive financial performance in the last quarter. The company's score has improved from 15 to 11 in the last three months, indicating a strong growth trajectory.
One of the key factors contributing to this positive performance is the company's net sales, which have been consistently growing in the last five quarters. In the last quarter, the net sales reached a record high of Rs 453.22 crore, showcasing a strong and steady growth trend. This is a positive sign for the company's near-term sales outlook.
Caplin Point Lab's operating profit (PBDIT) has also shown a similar trend, with a consistent growth in the last five quarters. In the last quarter, the operating profit reached its highest at Rs 145.23 crore, indicating a positive near-term trend.
The company's profit before tax (PBT) less other income has also seen a significant growth in the last five quarters, reaching its highest at Rs 128.74 crore in the last quarter. This showcases a strong and positive near-term trend for the company's profitability.
Caplin Point Lab's profit after tax (PAT) has also shown a consistent growth in the last five quarters, reaching its highest at Rs 121.59 crore in the last quarter. This is a positive sign for the company's near-term profitability.
The company's earnings per share (EPS) have also increased in the last five quarters, reaching its highest at Rs 16.01. This indicates that the company has been able to create higher earnings for its shareholders, showcasing its increasing profitability.
Overall, Caplin Point Laboratories has shown a strong and positive financial performance in the last quarter, with all key indicators showcasing a positive trend. This is a promising sign for the company's future growth and success in the pharmaceutical industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
